Tarnow-Mordi William O, Duley Lelia, Field David, Marlow Neil, Morris Jonathan, Newnham John, Paneth Nigel, Soll Roger F, Sweet David
WINNER Centre for Newborn Research, NHMRC Clinical Trials Centre, University of Sydney, Sydney, New South Wales, Australia.
Nottingham Clinical Trials Unit, Nottingham Health Science Partners, C Floor, South Block, Queen's Medical Centre, Nottingham, UK.
Am J Obstet Gynecol. 2014 Aug;211(2):118-23. doi: 10.1016/j.ajog.2014.03.055. Epub 2014 Mar 28.
In December 2012, the American College of Obstetricians and Gynecologists published a Committee Opinion entitled "Timing of umbilical cord clamping after birth." It stated that "evidence exists to support delayed cord clamping in preterm infants, when feasible. The single most important benefit for preterm infants is the possibility for a nearly 50% reduction in IVH." However, the Committee Opinion added that the ideal timing of umbilical cord clamping has yet to be determined and recommended that large clinical trials be conducted in the most preterm infants. Published randomized controlled trials include <200 infants of <30 weeks' gestation, with assessments of neurodevelopmental outcome in less than one-half of the children. This is a major gap in the evidence. Without reliable data from randomized controlled trials that optimally include childhood follow-up evaluations, we will not know whether delayed cord clamping may do more overall harm than good. Ongoing trials of delayed cord clamping plan to report childhood outcomes in >2000 additional very preterm infants. Current recommendations may need to change when these results become available. Greater international collaboration could accelerate resolution of whether this promising intervention will improve disability-free survival in about 1 million infants who will be born very preterm globally each year.
2012年12月,美国妇产科医师学会发表了一篇题为《出生后脐带结扎的时机》的委员会意见。该意见指出:“有证据支持在可行的情况下对早产儿延迟脐带结扎。对早产儿而言,最重要的益处是有可能使脑室内出血减少近50%。”然而,该委员会意见补充称,脐带结扎的理想时机尚未确定,并建议针对极早产儿开展大型临床试验。已发表的随机对照试验纳入的妊娠小于30周的婴儿不足200例,且对不到一半的儿童进行了神经发育结局评估。这是证据方面的一个重大缺口。如果没有来自随机对照试验的可靠数据(最好包括儿童期随访评估),我们就无法知晓延迟脐带结扎总体上是否弊大于利。正在进行的延迟脐带结扎试验计划报告另外2000多名极早产儿的儿童期结局。当这些结果公布时,目前的建议可能需要改变。加强国际合作可以加快解决这一有前景的干预措施能否提高全球每年约100万极早产儿无残疾存活几率的问题。